drugset
drugset / Trial / NCT04987970

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg

NCT04987970 ↗

Phase 1 Completed 60 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-386(2)

Timeline

Start
2021-09-12
Primary completion
2021-11-11
Completion
2021-11-27

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-386(2) Unknown — Oral
Subject D013 Unknown — Oral
Subject D326 Unknown — Oral
Subject D337 Unknown — Oral

Indications

No indication recorded.